432 reports of this reaction
2.6% of all NEVIRAPINE reports
#7 most reported adverse reaction
HIV INFECTION is the #7 most commonly reported adverse reaction for NEVIRAPINE, manufactured by Amneal Pharmaceuticals LLC. There are 432 FDA adverse event reports linking NEVIRAPINE to HIV INFECTION. This represents approximately 2.6% of all 16,383 adverse event reports for this drug.
Patients taking NEVIRAPINE who experience hiv infection should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HIV INFECTION is a less commonly reported adverse event for NEVIRAPINE, but still significant enough to appear in the safety profile.
In addition to hiv infection, the following adverse reactions have been reported for NEVIRAPINE:
HIV INFECTION has been reported as an adverse event in 432 FDA reports for NEVIRAPINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HIV INFECTION accounts for approximately 2.6% of all adverse event reports for NEVIRAPINE, making it a notable side effect.
If you experience hiv infection while taking NEVIRAPINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.